| Alum Bladder Irrigation - Prescribing and Administering Instructions
|
SESLHDPR/704 |
|
| Cannabis – Inpatient Management of patients admitted to SESLHD facilities using medicinal cannabis products
|
SESLHDPR/620 |
|
| CEC Infection Prevention and Control Practice Handbook
|
|
|
| Communication and Response Protocol for Border Health Incidents Related to an Infectious Disease
|
SESLHDPR/729 |
|
| Correct Identification of Medication and Solutions for Regional Anaesthetic Procedures
|
SESLHDPR/242 |
|
| Guide for issuing an “Inability to Treat Notice” to violent patients
|
SESLHDGL/110 |
|
| Health, Safety and Wellbeing - Incident Investigation
|
SESLHDPR/322 |
|
| Inactivating Encounters or Documents in the eMR
|
SESLHDPR/718 |
|
| Infection Control: Cleaning (Shared) Patient Care Equipment
|
SESLHDGL/029 |
|
| Infection Prevention and Control during construction, renovation or maintenance
|
SESLHDPR/374 |
|
| Infective Complications - Mandatory reporting requirements of peripheral intravenous cannula (PIVC) or central venous access device (CVAD) infections in the incident management system (ims+)
|
SESLHDPD/280 |
|
| Influenza Clinics for Seasonal Influenza
|
SESLHDPR/277 |
|
| Influenza – Critical Care Escalation and Management
|
SESLHDPR/270 |
|
| Information Security Incident Management
|
SESLHDPD/317 |
|
| Information Security Policy
|
SESLHDPD/310 |
|
| Injury Management - Non-Work Related Injury or Illness Management
|
SESLHDPR/564 |
|
| Injury Management – Redeployment of Injured Employees under Workers Compensation
|
SESLHDPR/279 |
|
| Insulin Glargine High Concentration 300 units/mL (Toujeo®)
|
|
|
| Internet of Things (IoT)
|
SESLHDPD/312 |
|
| Intra-Pleural Fibrinolysis - Medical Management of Empyema
|
SESLHDPR/631 |
|
| Intravenous to Oral Antimicrobial Switch
|
SESLHDGL/115 |
|
Iron Infusions
Medicine Guidelines:
|
SESLHDPR/753 |
|
| Managing Notifiable Incidents and Regulator Interactions
|
SESLHDPR/269 |
|
| Medicare Ineligible Patients – General Fees
|
SESLHDPR/425 |
|
| Medicine: Managing Intraoperative Medications
|
SESLHDPR/209 |
|
| New or altered interventional procedures, technologies including devices, implants, point of care (POC) diagnostic machines and treatments – safe introduction into clinical practice
|
SESLHDPD/286 |
|
| Nursing and Midwifery Delegation: Ordering of Pathology and Imaging in eMR
|
SESLHDPD/303 |
|
| Pain Management - Implantable Intrathecal Drug Delivery System
|
SESLHDPR/294 |
|
| Preferred ICT Platforms for Collaboration and Video Conferencing within SESLHD
|
SESLHDPD/334 |
|
| Preparation and Safe Use of Infant Formula
|
SESLHDGL/085 |
|
| Radiation Safety - Ionising Radiation
|
SESLHDPD/296 |
|
| Release of Patient Health Information - Secure Organisations
|
SESLHDPR/757 |
|
| Release of Patient Health Information Related to an Insurance / Compensation Claim
|
SESLHDPR/675 |
|
| Reporting and Escalation of Serious Incidents
|
SESLHDPR/549 |
|
| SESLHD workers and students unvaccinated for influenza must wear a mask while providing patient care in a high risk clinical area
|
SESLHDPD/307 |
|
| Working in Isolation Risk Management
|
SESLHDPR/323 |
|
| Wound - Incontinence Associated Dermatitis (IAD)
|
SESLHDPR/205 |
|
